Table 1.
Osteoblasts | ||||||
---|---|---|---|---|---|---|
Day | Alendronate 5 μM | P-value | Omeprazole 1 μM | P-value | Alendronate + omeprazole | P-value |
1 | 100.5 ± 2.6 | 0.872 | 95.8 ± 2.1 | 0.140 | 99.1 ± 0.9 | 0.492 |
3 | 103.4 ± 2.9 | 0.378 | 93.3 ± 3.4 | 0.150 | 98.1 ± 3.6 | 0.658 |
Fibroblasts | ||||||
---|---|---|---|---|---|---|
Day | Alendronate 5 μM | P-value | Omeprazole 1 μM | P-value | Alendronate + omeprazole | P-value |
1 | 107.9 ± 2.6 | 0.070 | 102.4 ± 2.2 | 0.442 | 98.8 ± 1.2 | 0.609 |
3 | 99.4 ± 3.0 | 0.866 | 98.9 ± 3.5 | 0.770 | 101.1 ± 1.7 | 0.580 |
The effect was measured after 1 and 3 days of incubation with 5 μM ALN, 1 μM OME and ALN + OME.